Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Home

About Us

Gregory H. Bailey, M.D.

Managing Partner
Palantir Group, Inc.

Dr. Bailey has been managing partner of Palantir Group, Inc., a biotechnology merchant bank, since 2007. He was managing director of investment banking at MDB Capital Group from 2004 to 2007, and a life sciences analyst at Participating Capital from 1995 to 2004. Dr. Bailey holds an M.D. degree from the University of Western Ontario.

Top

Contact
Sitemap
Terms of Use
Site by Formative